Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19.

MLA

Kazemi-Sufi, Siamak, et al. “Serum Proinflammatory Cytokines, Receptor Activator of Nuclear Factor Kappa-Β Ligand (RANKL), Osteoprotegerin (OPG) and RANKL/OPG Ratio in Mild and Severe COVID-19.” BMC Infectious Diseases, vol. 24, no. 1, Sept. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12879-024-09941-6.

APA

Kazemi-Sufi, S., Alipour, S., Rabieepour, M., Roshan-Milani, S., & Naderi, R. (2024). Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19. BMC Infectious Diseases, 24(1), 1–9. https://doi.org/10.1186/s12879-024-09941-6

Chicago

Kazemi-Sufi, Siamak, Shahriar Alipour, Masome Rabieepour, Shiva Roshan-Milani, and Roya Naderi. 2024. “Serum Proinflammatory Cytokines, Receptor Activator of Nuclear Factor Kappa-Β Ligand (RANKL), Osteoprotegerin (OPG) and RANKL/OPG Ratio in Mild and Severe COVID-19.” BMC Infectious Diseases 24 (1): 1–9. doi:10.1186/s12879-024-09941-6.